Objective: To evaluate the pharmacokinetics and cost of once-daily dosing with gentamicin in women with postpartum endometritis.
entamicin remains a popular bacteriocidal antibiotic for the treatment of infections caused by gram-negative organisms. Postpartum endometritis, typically a polymicrobial infection of both aerobic and anaerobic organisms, is often treated with clindamycin and gentamicin for broadspectrum coverage. While it is a highly effective antibiotic, gentamicin is associated with potentially serious toxicity, including nephrotoxicity and ototoxicity. A review of prospective clinical trials of adult patients treated with aminoglycosides between 1975 and 1982 Based on a 3-day course of gentamicin, the patient charge from our pharmacy for the once-daily regimen was $241, compared with $422 for the thrice-daily regimen. After adding nursing administration times, the total patient charges were $250 and $449 respectively. This represents a 44% re-duction in patient charges for the once-daily regimen when compared with the thrice-daily regimen for 72 hours of treatment.
DISCUSSION
This study demonstrates several important points regarding a once-daily dose of gentamicin among postpartum women. Our data show that no drug accumulation occurred during our treatment period, as trough levels were consistently less than 0.3 mg/L. This is important clinically as data suggests that aminoglycoside-free periods during therapy are necessary to reduce the risk of nephrotoxicity and ototoxicity. 7 We were also able to consistently achieve elevated peak levels with our dosing regimen, optimizing the PAE and concentrationdependent killing characteristics of aminoglycoside antibiotics. 7 9 An additional factor that may reflect a higher half life is that our laboratory could not detect gentamicin levels less than 0.3 rag/L, the trough value used to calculate the half life. Higher trough levels lengthen the half life. Finally, we were able to demonstrate significant cost savings with a oncedaily regimen in the postpartum patient with endometritis, reducing charges by nearly one half. The results of this study support the conclusions of two reports of once-daily gentamicin in the treatment of puerperal uterine infections. 9,1 Oncedaily dosing of gentamicin for the treatment of postpartum endometritis is efficacious and costeffective, and it appears that this regimen is not associated with a high incidence of nephrotoxicity or ototoxicity.
